BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7742549)

  • 41. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
    Quelle DE; Ashmun RA; Shurtleff SA; Kato JY; Bar-Sagi D; Roussel MF; Sherr CJ
    Genes Dev; 1993 Aug; 7(8):1559-71. PubMed ID: 8339933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
    Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
    Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
    Avet-Loiseau H; Garand R; Gaillard F; Daviet A; Mellerin MP; Robillard N; Bouyge I; Arcot S; Batzer M; Talmant P; Harousseau JL; Milpied N; Bataille R
    Genes Chromosomes Cancer; 1998 Oct; 23(2):175-82. PubMed ID: 9739021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immature stage B cells enter but do not progress beyond the early G1 phase of the cell cycle in response to antigen receptor signaling.
    Carman JA; Wechsler-Reya RJ; Monroe JG
    J Immunol; 1996 Jun; 156(12):4562-9. PubMed ID: 8648097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
    Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
    Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes.
    Tanguay DA; Chiles TC
    J Immunol; 1996 Jan; 156(2):539-48. PubMed ID: 8543804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo.
    Sun W; Lee DK; Lee CC; Kim K
    Mol Reprod Dev; 1996 Apr; 43(4):414-20. PubMed ID: 9052931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma.
    Cohen AM; Grinblat B; Bessler H; Kristt D; Kremer A; Schwartz A; Halperin M; Shalom S; Merkel D; Don J
    Leuk Lymphoma; 2004 May; 45(5):951-5. PubMed ID: 15291354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1.
    Loyer P; Cariou S; Glaise D; Bilodeau M; Baffet G; Guguen-Guillouzo C
    J Biol Chem; 1996 May; 271(19):11484-92. PubMed ID: 8626707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells.
    Ando K; Ajchenbaum-Cymbalista F; Griffin JD
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9571-5. PubMed ID: 8415743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
    Iwanaga R; Ohtani K; Hayashi T; Nakamura M
    Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Over-expression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13.
    Delmer A; Ajchenbaum-Cymbalista F; Tang R; Ramond S; Faussat AM; Marie JP; Zittoun R
    Br J Haematol; 1995 Apr; 89(4):798-804. PubMed ID: 7772515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis.
    Belsõ N; Széll M; Pivarcsi A; Kis K; Kormos B; Kenderessy AS; Dobozy A; Kemény L; Bata-Csörgõ Z
    J Invest Dermatol; 2008 Mar; 128(3):634-42. PubMed ID: 17882269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins.
    Maeda A; Bandobashi K; Nagy N; Teramoto N; Gogolák P; Pokrovskaja K; Székely L; Björkholm M; Klein G; Klein E
    J Hum Virol; 2001; 4(5):227-37. PubMed ID: 11907380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia.
    Ciszak L; Frydecka I; Wolowiec D; Szteblich A; Kosmaczewska A
    Clin Exp Med; 2016 Aug; 16(3):317-32. PubMed ID: 26003188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFNgamma in macrophages.
    Dey A; Li W
    Biochim Biophys Acta; 2000 Jun; 1497(1):135-47. PubMed ID: 10838167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
    Williams ME; Swerdlow SH
    Ann Oncol; 1994; 5 Suppl 1():71-3. PubMed ID: 8172823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.
    Korz C; Pscherer A; Benner A; Mertens D; Schaffner C; Leupolt E; Döhner H; Stilgenbauer S; Lichter P
    Blood; 2002 Jun; 99(12):4554-61. PubMed ID: 12036888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2.
    Klier M; Anastasov N; Hermann A; Meindl T; Angermeier D; Raffeld M; Fend F; Quintanilla-Martinez L
    Leukemia; 2008 Nov; 22(11):2097-105. PubMed ID: 18685613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.